| APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa RJ Cho, LB Alexandrov, NY Den Breems, VS Atanasova, M Farshchian, ... Science Translational Medicine 10 (455), eaas9668, 2018 | 109 | 2018 |
| Amlexanox enhances premature termination codon read-through in COL7A1 and expression of full length type VII collagen: potential therapy for recessive dystrophic epidermolysis … VS Atanasova, Q Jiang, M Prisco, C Gruber, JP Hofbauer, M Chen, C Has, ... Journal of Investigative Dermatology 137 (9), 1842-1849, 2017 | 92 | 2017 |
| Thrombospondin-1 is a major activator of TGF-β signaling in recessive dystrophic epidermolysis bullosa fibroblasts VS Atanasova, RJ Russell, TG Webster, Q Cao, P Agarwal, YZ Lim, ... Journal of Investigative Dermatology 139 (7), 1497-1505. e5, 2019 | 59 | 2019 |
| Identification of rigosertib for the treatment of recessive dystrophic epidermolysis bullosa–associated squamous cell carcinoma VS Atanasova, C Pourreyron, M Farshchian, M Lawler, CA Brown IV, ... Clinical Cancer Research 25 (11), 3384-3391, 2019 | 33 | 2019 |
| IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer E Koncina, M Nurmik, VI Pozdeev, C Gilson, M Tsenkova, R Begaj, ... Nature communications 14 (1), 4251, 2023 | 15 | 2023 |
| Mimicking tumor cell heterogeneity of colorectal cancer in a patient-derived organoid-fibroblast model VS Atanasova, C de Jesus Cardona, V Hejret, A Tiefenbacher, T Mair, ... Cellular and Molecular Gastroenterology and Hepatology 15 (6), 1391-1419, 2023 | 12 | 2023 |
| Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico AH Saeidian, L Youssefian, MG Moreno Trevino, G Fortuna, ... Clinical and Experimental Dermatology 43 (5), 579-584, 2018 | 12 | 2018 |
| Precision medicine for heritable skin diseases—the paradigm of epidermolysis bullosa J Uitto, VS Atanasova, Q Jiang, AP South Journal of Investigative Dermatology Symposium Proceedings 19 (2), S74-S76, 2018 | 8 | 2018 |
| APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Sci Transl Med. 2018 RJ Cho, LB Alexandrov, NY den Breems, VS Atanasova, M Farshchian, ... Přejít k původnímu zdroji... Přejít na PubMed, 0 | 6 | |
| Selective eradication of colon cancer cells harboring PI3K and/or MAPK pathway mutations in 3D culture by combined PI3K/AKT/mTOR pathway and MEK inhibition VS Atanasova, A Riedl, M Strobl, J Flandorfer, D Unterleuthner, ... International Journal of Molecular Sciences 24 (2), 1668, 2023 | 4 | 2023 |
| 482P Identification of proteome and secretome signatures in primary colorectal cancer associated fibroblasts VS Atanasova, A Tiefenbacher, J Clement, K Wöran, M Bergmann, ... Annals of Oncology 31, S445, 2020 | 1 | 2020 |
| First report of COL7A1 mutations in two patients with recessive dystrophic epidermolysis bullosa from Peru AH Saeidian, L Youssefian, GM Rosales‐Solis, H Vahidnezhad, ... Clinical and Experimental Dermatology 43 (6), 719-722, 2018 | 1 | 2018 |
| P11. 02 A complex human tumor organoid model consisting of malignant cells, fibroblasts and immune cells enlights the effect of chemotherapy-induced senescent tumor cells on NK … D Ammon, M Fabits, M Sykora, J Kabiljo, A Theophil, V Atanasova, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 1), 2024 | | 2024 |
| P04. 04 Single cell transcriptomics reveals cancer associated fibroblasts enable modeling of tumor associated macrophage like phenotypes and treatment responses in primary … J Kabiljo, A Theophil, J Homola, A Renner, J Karall, N Hartman, S Stang, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 1), 2024 | | 2024 |
| Abstract A011: Epigenetic vulnerabilities in patient-derived colorectal cancer organoids L Tran, RS Tezerji, CUP Malla, A Malzer, A Logo, K Misura, T Mair, ... Cancer Research 82 (23_Supplement_2), A011-A011, 2022 | | 2022 |
| P09. 19 Complex primary organoid cultures to dissect immunogenic effects of therapy on macrophages in a precision medicine-like approach J Kabiljo, J Homola, A Theophil, J Karall, N Hartman, L Tran, J Laengle, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 1), 2022 | | 2022 |
| P09. 18 TNF induction in essential for oncolytic influenza A virus induced cancer regression and tumor associated macrophage repolarization J Homola, J Kabiljo, A Theophil, N Hartman, I Kovacs, J Karall, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 1), 2022 | | 2022 |
| Absence of collagen VII binding to thrombospondin 1 promotes activation of TGF-beta in recessive dystrophic epidermolysis bullosa VS Atanasova, R Russel, TG Webster, P Agarwal, S Krishnan, J Salas, ... Journal of Investigative Dermatology 138 (5), S147-S147, 2018 | | 2018 |
| Novel Therapeutic Approaches for Recessive Dystrophic Epidermolysis Bullosa VS Atanasova Thomas Jefferson University, 2018 | | 2018 |
| 664 Thrombospondin 1 is a major activator of TGF-beta in Recessive Dystrophic Epidermolysis Bullosa VS Atanasova, R Russell, TG Webster, J Salas, A South Journal of Investigative Dermatology 137 (10), S307, 2017 | | 2017 |
